TRIM21 and non-small cell lung carcinoma: Regardless of the changes in the cellular microenvironment, there is a tendency for TRIM21/Ro52 inactivation to result in higher PFK1 expression and higher glycolysis rates in human non-small-cell-lung-cancer cells [109].